Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.79%
)
Brent Oil
91.65
(
-1.09%
)
Bitcoin
74,664.68
(
1.09%
)
News Focus
News Focus
Post# of 3310
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3160
Posts 967881
Boards Moderated 152
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 3050

Saturday, 09/22/2007 6:07:45 PM

Saturday, September 22, 2007 6:07:45 PM

Post# of 3310
Amgen announces Vectibix receives "positive" opinion for marketing authorization in the European Union (AMGN) 55.80 +0.49 : Co announces that the European Committee for Medicinal Products for Human Use has issued a "positive" opinion recommending a conditional marketing authorization for Vectibix in the European Union for patients with refractory metastatic colorectal cancer with non-mutated KRAS genes.



Caspermick

"TOUGH TIMES NEVER LAST BUT TOUGH PEOPLE DO."


God Bless America

In Gambling,,,Playing Card Games. Ya Never Know What The Next Hand Will Look Like.
Ten Bagger Potential Stock

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today